[1] [2] Common GLP-1 medications include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), while tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist
Fig.4 Efficacy evaluation of semaglutide and tirzepatide in HFD+CCl 4 -Induced MASH Mouse Models A
Nevertheless, interindividual response variability, high cost, and adherence challenges may limit widespread clinical implementation
BD Biosciences) and anti-human CD66b (FITC
8 weeks: 4 mL used across 2 vials
Risks include gastrointestinal side effects (nausea, vomiting, diarrhea) that may worsen disordered eating, potential for pancreatitis and gallbladder disease, and unknown psychological impacts in eating disorder populations